RxSight (RxSight) Net Margin % : -30.83% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is RxSight Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. RxSight's Net Income for the three months ended in Mar. 2024 was $-9.1 Mil. RxSight's Revenue for the three months ended in Mar. 2024 was $29.5 Mil. Therefore, RxSight's net margin for the quarter that ended in Mar. 2024 was -30.83%.

The historical rank and industry rank for RxSight's Net Margin % or its related term are showing as below:

RXST' s Net Margin % Range Over the Past 10 Years
Min: -215.5 Med: -54.57 Max: 5632.31
Current: -44.01

RXST's Net Margin % is ranked worse than
68.09% of 821 companies
in the Medical Devices & Instruments industry
Industry Median: -1.03 vs RXST: -44.01

RxSight Net Margin % Historical Data

The historical data trend for RxSight's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RxSight Net Margin % Chart

RxSight Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

5,632.31

187.87

-215.50

-136.22

-54.57

RxSight Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Margin %	Get a 7-Day Free Trial													-75.54	-66.33	-55.93	-32.11	-30.83

Competitive Comparison of RxSight's Net Margin %

For the Medical Devices subindustry, RxSight's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RxSight's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, RxSight's Net Margin % distribution charts can be found below:

* The bar in red indicates where RxSight's Net Margin % falls into.

RxSight Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

RxSight's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-48.608	/	89.077
	=	-54.57 %

RxSight's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin	=	Net Income (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-9.1	/	29.512
	=	-30.83 %

RxSight (NAS:RXST) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

RxSight Net Margin % Related Terms

Thank you for viewing the detailed overview of RxSight's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

RxSight (RxSight) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » RxSight Inc (NAS:RXST) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Columbia, Aliso Viejo, CA, USA, 92656

Website

https://www.rxsight.com

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery.

Executives

Ilya Goldshleger	officer: Chief Operating Officer	C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Eric Weinberg	officer: Chief Commercial Officer	C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Shweta Maniar	director	C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Jesse Anderson Corley	director	C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Kurtz Ronald M Md	director, officer: See Remarks	C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Robert Keith Warner	director	C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Shelley B Thunen	officer: Chief Financial Officer	C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Bakker Juliet Tammenoms	director	LONGITUDE CAPITAL MANAGEMENT CO., LLC, 800 EL CAMINO REAL, SUITE 220, MENLO PARK CA 94025
Tamara Fountain	director	C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Robert J Palmisano	director	110 HARTWELL AVENUE, LEXINGTON MA 02173
Link William J Phd	director, 10 percent owner	ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO CA 94104
Julie Andrews	director	5677 AIRLINE ROAD, ARLINGTON TN 38002
Rajeev M. Shah	10 percent owner	200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Peter Kolchinsky	10 percent owner	200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Ra Capital Management, L.p.	10 percent owner	200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116